A new model to evaluate the market for biotechnology

Journal of Commercial Biotechnology

Volumn 10, Issue 1, 2003, Pages 78-84

  McMurray, Amanda ^a   Jones, Richard ^b  

^a Babraham Bioscience Technologies Ltd   (United Kingdom)

^b ITNET plc

Author keywords

Biotechnology; Marketing; Model; Positioning; Segmentation

Indexed keywords

DNA;

ARTICLE; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; COMPETITION; CONTROLLED STUDY; DNA SEQUENCE; FINANCIAL MANAGEMENT; GENOTYPE; MARKETING; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM;

EID: 3042816519     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3040057     Document Type: Article

References (5)

1. Moore, G. A. (1991), 'Crossing the Chasm: Marketing and Selling Technology Products to Mainstream Customers', 2nd edn, Harper Business, New York.
2. Moore, G. A. (1998), 'Inside the Tornado: Marketing Strategies from Silicon Valley's Cutting Edge', HarperCollins Publishers Inc., New York.
3. Robertson, T. S. (1971), 'Innovative Communication and Behaviour', Holt, Rinehart and Winston, Inc., New York.
4. LaPlaca, P. J. and Punj, G. (1989) 'The marketing challenge: Factors affecting the adoption of high technology innovations', in Smilor, R. W. Ed., 'Customer-Driven Marketing: Lessons from Entrepreneurial Technology Companies', Lexington Books, Lexington, MA.
5. Porter, M. (1980) 'Competitive Strategy: Techniques for Analysing Industries and Competitors', Free Press, New York.